Céline Berthon

6.0k total citations · 1 hit paper
77 papers, 2.1k citations indexed

About

Céline Berthon is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Céline Berthon has authored 77 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Hematology, 22 papers in Molecular Biology and 19 papers in Oncology. Recurrent topics in Céline Berthon's work include Acute Myeloid Leukemia Research (39 papers), Acute Lymphoblastic Leukemia research (15 papers) and Multiple Myeloma Research and Treatments (14 papers). Céline Berthon is often cited by papers focused on Acute Myeloid Leukemia Research (39 papers), Acute Lymphoblastic Leukemia research (15 papers) and Multiple Myeloma Research and Treatments (14 papers). Céline Berthon collaborates with scholars based in France, United Kingdom and Germany. Céline Berthon's co-authors include Bruno Quesnel, Claude Preudhomme, Emmanuel Raffoux, Nathalie Jouy, Dominique Hétuin, Christophe Roumier, Christian Récher, Xavier Leleu, Norbert Vey and Hervé Dombret and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Oncogene.

In The Last Decade

Céline Berthon

74 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bromodomain inhibitor OTX015 in patients with acute leukaemia: a dose-escalation, phase 1 study

2016 336 citations Céline Berthon, Christophe Roumier et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Céline Berthon France	22	1.3k	899	496	462	370	77	2.1k
Yukiyasu Ozawa Japan	23	1.4k 1.1×	564 0.6×	463 0.9×	470 1.0×	249 0.7×	188	2.1k
José Cervera Spain	29	1.5k 1.2×	1.4k 1.6×	341 0.7×	487 1.1×	519 1.4×	129	2.6k
Christine Hartford United States	22	684 0.5×	574 0.6×	339 0.7×	459 1.0×	213 0.6×	36	1.7k
Maximilian Stahl United States	25	1.3k 1.0×	970 1.1×	466 0.9×	236 0.5×	387 1.0×	121	2.0k
Hsi‐Che Liu Taiwan	17	762 0.6×	703 0.8×	225 0.5×	627 1.4×	200 0.5×	73	1.6k
Susan O’Brien United States	29	2.2k 1.8×	949 1.1×	575 1.2×	686 1.5×	1.3k 3.4×	69	3.1k
Robert Schoch Germany	12	1.7k 1.4×	972 1.1×	282 0.6×	352 0.8×	604 1.6×	21	2.3k
Sandrine Meyer‐Monard Switzerland	21	1.0k 0.8×	607 0.7×	522 1.1×	232 0.5×	198 0.5×	42	1.8k
Lia Perez United States	22	940 0.7×	322 0.4×	441 0.9×	223 0.5×	179 0.5×	80	1.3k
Sílvia Regina Brandalise Brazil	23	364 0.3×	813 0.9×	408 0.8×	489 1.1×	193 0.5×	91	1.8k

Countries citing papers authored by Céline Berthon

Since Specialization

Citations

This map shows the geographic impact of Céline Berthon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Céline Berthon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Céline Berthon more than expected).

Fields of papers citing papers by Céline Berthon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Céline Berthon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Céline Berthon. The network helps show where Céline Berthon may publish in the future.

Co-authorship network of co-authors of Céline Berthon

This figure shows the co-authorship network connecting the top 25 collaborators of Céline Berthon. A scholar is included among the top collaborators of Céline Berthon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Céline Berthon. Céline Berthon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lebon, Delphine, Véronique Harrivel, Alice Marceau‐Renaut, et al.. (2025). Monitoring of measurable residual disease by next‐generation sequencing in patients with acute myeloid leukaemia. British Journal of Haematology. 207(5). 1953–1961. 1 indexed citations

Berthon, Céline, Valérie Soenen, Alice Marceau‐Renaut, et al.. (2024). Unravelling a KMT2A::ARHGEF12 fusion within chromoanagenesis in acute myeloid leukemia using Optical Genome Mapping. Annals of Hematology. 103(11). 4793–4795. 2 indexed citations

Berthon, Céline, et al.. (2023). French Retrospective Database Analysis of Patient Characteristics and Treatment Patterns in Patients with R/R FLT3-Mutated AML: A Registry-Based Cohort Study. Oncology and Therapy. 11(3). 375–389.

Jouy, Nathalie, Valério Farfariello, Thierry Idziorek, et al.. (2022). Involvement of ORAI1/SOCE in Human AML Cell Lines and Primary Cells According to ABCB1 Activity, LSC Compartment and Potential Resistance to Ara-C Exposure. International Journal of Molecular Sciences. 23(10). 5555–5555. 5 indexed citations

Fournier, Élise, Camille Debord, Valérie Soenen, et al.. (2020). Baseline dysmegakaryopoiesis in inherited thrombocytopenia/platelet disorder with predisposition to haematological malignancies. British Journal of Haematology. 189(4). e119–e122. 8 indexed citations

Berthon, Céline, et al.. (2020). Acute myeloid leukemia synchronous with multiple myeloma successfully treated by azacytidine/lenalidomide and daratumumab without a decrease in myeloid clone size. Leukemia Research Reports. 13. 100202–100202. 3 indexed citations

Boyer, Thomas, Adeline Barthélémy, Alice Marceau‐Renaut, et al.. (2019). Clinical Significance of ABCB1 in Acute Myeloid Leukemia: A Comprehensive Study. Cancers. 11(9). 1323–1323. 29 indexed citations

Willekens, Christophe, Aline Renneville, Sophie Broutin, et al.. (2018). Mutational profiling of isolated myeloid sarcomas and utility of serum 2HG as biomarker of IDH1/2 mutations. Leukemia. 32(9). 2008–2081. 17 indexed citations

Boyer, Thomas, Pauline Peyrouze, Soizic Guihard, et al.. (2017). Targeting Aberrant Expression of CD81 Impacts Cell Adhesion and Migration, Drug Resistance and Prognosis of Acute Myeloid Leukemia. Blood. 130. 2675–2675. 3 indexed citations

10.

Duployez, Nicolas, Olivier Nibourel, Nathalie Grardel, et al.. (2016). Acquisition of genomic events leading to lymphoblastic transformation in a rare case of myeloproliferative neoplasm with BCR–JAK2 fusion transcript. European Journal Of Haematology. 97(4). 399–402. 6 indexed citations

11.

Smol, Thomas, Olivier Nibourel, Alice Marceau‐Renaut, et al.. (2015). Quantification of EVI1 transcript levels in acute myeloid leukemia by RT-qPCR analysis: A study by the ALFA Group. Leukemia Research. 39(12). 1443–1447. 9 indexed citations

12.

Harel, Stéphanie, Céline Berthon, Christophe Willekens, et al.. (2015). Outcome of patients with high risk Myelodysplastic Syndrome (MDS) and advanced Chronic Myelomonocytic Leukemia (CMML) treated with decitabine after azacitidine failure. Leukemia Research. 39(5). 501–504. 38 indexed citations

13.

Cornet, Édouard, Christophe Roumier, Pascale Lepelley, et al.. (2012). Involvement of a common progenitor cell in core binding factor acute myeloid leukaemia associated with mastocytosis. Leukemia Research. 36(11). 1330–1333. 6 indexed citations

14.

Kuranda, Klaudia, Céline Berthon, Frédéric Leprêtre, et al.. (2011). Expression of CD34 in hematopoietic cancer cell lines reflects tightly regulated stem/progenitor‐like state. Journal of Cellular Biochemistry. 112(5). 1277–1285. 13 indexed citations

15.

Berthon, Céline, Sélim Corm, Jason Gay, et al.. (2011). Vancomycin serum concentration during febrile neutropenia in patients with acute myeloid leukemia. Médecine et Maladies Infectieuses. 41(12). 652–656. 15 indexed citations

16.

Preudhomme, Claude, Nathalie Hélevaut, Olivier Nibourel, et al.. (2011). Minimal residual disease monitoring based on FLT3 internal tandem duplication in adult acute myeloid leukemia. Leukemia Research. 36(3). 316–323. 44 indexed citations

17.

Berthon, Céline, Virginie Driss, Jizhong Liu, et al.. (2010). In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors. Cancer Immunology Immunotherapy. 59(12). 1839–1849. 133 indexed citations

18.

Kuranda, Klaudia, Céline Berthon, Caroline Dupont, et al.. (2009). A subpopulation of malignant CD34+CD138+B7-H1+ plasma cells is present in multiple myeloma patients. Experimental Hematology. 38(2). 124–131.e4. 26 indexed citations

19.

Micol, Jean‐Baptiste, Céline Berthon, Sabine Tricot, et al.. (2007). Allogeneic stem-cell transplantation with fludarabine and 2-Gy TBI-based conditioning regimen for chronic hematological malignancy: A study of 25 consecutive patients and a literature review. Leukemia & lymphoma. 48(2). 321–329. 3 indexed citations

20.

Leleu, Xavier, Louis Terriou, Anne‐Sophie Moreau, et al.. (2006). Long-term outcome in acquired aplastic anemia treated with an intensified dose schedule of horse antilymphocyte globulin in combination with androgens. Annals of Hematology. 85(10). 711–716. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact